[Optimized compliance].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000627:therapeutic use*; D008134:Long-Term Care; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy / Q000451:nursing* / Q000523:psychology; D024802:Nurse's Role / Q000523:psychology*; D010349:Patient Compliance / Q000523:psychology*; D010352:Patient Dropouts / Q000523:psychology; D010353:Patient Education as Topic; D012657:Self-Help Groups; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D016899:Interferon-beta; D000068556:Interferon beta-1a